FDA NDC Directory · JSON-LD · Markdown

Enspryng

NDC 50242-005 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameSatralizumab
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA761149
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsSATRALIZUMAB (180 mg/1.5mL)
Marketing started20261015
Package count2

External sources

Source: openFDA. Public-domain (CC0).